A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM

Diabetes

Volumn 45, Issue 9, 1996, Pages 1204-1208

  Fogarty, Damian G ^a   Harron, J Camille ^a   Hughes, Anne E ^b   Nevin, Norman C ^b   Doherty, Ciaran C ^a   Maxwell, A Peter ^a,b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ADOLESCENT; ADULT; ARTICLE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS;

EID: 0029793069     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.9.1204     Document Type: Article

References (35)

1. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
2. U.S. Renal Data System: USRDS 1994 Annual Data Report: incidence and causes of treated renal disease. Am J Kidney Dis 24 (Suppl. 2): S48-S56, 1994
3. Raine AEG: The rising tide of diabetic nephropathy: the warning before the flood. Nephrol Dial Transplant 10:460-461, 1995
4. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiological study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
5. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1993
6. Lane P, Steffes MW, Mauer SM: Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 41:581-586, 1992
7. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
8. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving H-H: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
9. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 295:515-517, 1987
10. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140- 145, 1988
11. Microalbuminuria Collaborative Study Group UK: Risk factors for devel- opment of microalbuminuria in insulin-dependent diabetic patients: a cohort study. Br Med J 306:1235-1239, 1993
12. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
13. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-689, 1982
14. Viberti GC, Mogensen CE, Groop LC, Pauls JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275-279, 1994
15. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charm A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P: Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-180, 1992
16. Cauffield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633, 1994
17. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95:948-953, 1995
18. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93:1285-1287, 1994
19. Cantor RM, Rotter JI: Analysis of genetic data: methods and interpretation. In The Genetic Basis of Common Disease. King RA, Rotter JI, Motulsky AG, Eds. New York, Oxford University Press, 1992, p. 49
20. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W: Rapid detection of the hypertension-associated Met 235 → Thr allele of the human angiotensinogen gene. Hum Mol Genet 2:609-610, 1993
21. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, Ogihara T: Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 8:521-524, 1994
22. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotemihen B, Ward R: Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans. Hypertension 24:591-594, 1994
23. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 90:2207-2212, 1994
24. Morise T, Takeuchi Y, Takeda R: Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hyperten- sion. J Intern Med 237:175-180, 1995
25. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F: Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 13:311-317, 1995
26. Walker WG, Whelton PK, Saito H, Russel RP, Herman J: Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone, and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1:287-291, 1979
27. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Jacob H, Fuxe K, Ganten D, Kaling M: High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11:821- 827, 1992
28. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentin AJ: Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 18:763-773, 1991
29. Whiteside CI, Thompson J: The role of angiotensin-II in progressive diabetic glomerulopathy in the rat. Endocrinology 125:1932-1940, 1989
30. Anderson PW, Do YS, Hsueh WA: Angiotensin II causes mesangial cell hypertrophy. Hypertension 21:29-35, 1993
31. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of micro-albuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1985
32. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Is blood pressure a predictor of incidence and progression of diabetic retinopathy? Arch Intern Med 149:2427-2432, 1989
33. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
34. Krolewski AS, Doria A, Magre J, Warram JH, Housraan D: Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol 3:S9-S17, 1992
35. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345:1600-1603, 1995